» Articles » PMID: 19373907

Implications of the Proposed Thyroid Fine-needle Aspiration Category of "follicular Lesion of Undetermined Significance": A Five-year Multi-institutional Analysis

Overview
Specialties Cell Biology
Pathology
Date 2009 Apr 18
PMID 19373907
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

National Cancer Institute State of the Science Conference on thyroid fine-needle aspiration (FNA) summarized diagnostic terminology. Six diagnostic categories were proposed including "follicular lesion of undetermined significance" (FLUS). FLUS was defined as findings neither convincingly benign nor sufficiently atypical for a diagnosis of "follicular neoplasm" or "suspicious for malignancy." It was proposed that this category represent less than 7% of thyroid FNAs. A search of the cytology records at three University Hospitals was performed for the term FLUS or older equivalent terms. Usage of FLUS was compared between institutions and among pathologists. Surgical pathology outcome for FLUS cases was determined. Twenty-eight pathologists evaluated 6,872 cases at the three institutions. Use of FLUS varied among pathologists (2.5 to 28.6%). Frequency of use of FLUS among institutions varied from 3.3 to 14.9%. FLUS cases [127 of 673 (18.9%)] underwent surgical exploration with malignancy identified in 36 cases (28.3%) undergoing resection. Use of FLUS varied substantially among pathologists and institutions. FLUS category requires more rigorously defined morphologic criteria for it to become a useful guide in clinical management.

Citing Articles

Correlation of Thyroid Fine Needle Aspiration Biopsy With Histopathological Results.

Durgun C Cureus. 2023; 15(5):e39130.

PMID: 37378189 PMC: 10292013. DOI: 10.7759/cureus.39130.


The Indian Academy of Cytologists Guidelines for Reporting Serous Effusion (IACGRSE): An Interobserver Agreement Analysis.

Nagose V, Kamal M, Kathuria S, Laddhad S J Cytol. 2022; 39(3):121-125.

PMID: 36277801 PMC: 9585817. DOI: 10.4103/joc.joc_50_22.


Longitudinal Assessment of Quality of Life Following Molecular Testing for Indeterminate Thyroid Nodules.

Schumm M, Nguyen D, Kim J, Tseng C, Chow A, Shen N Ann Surg Oncol. 2021; 28(13):8872-8881.

PMID: 34292427 PMC: 8591007. DOI: 10.1245/s10434-021-10375-6.


The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study.

Anand B, Ramdas A, Ambroise M, Kumar N J Thyroid Res. 2020; 2020:8095378.

PMID: 32351679 PMC: 7182964. DOI: 10.1155/2020/8095378.


Prospective Study of Bethesda Categories III and IV Thyroid Nodules: Outcomes and Predictive Value of BRAF Mutation.

Chirayath S, Pavithran P, Abraham N, Nair V, Bhavani N, Kumar H Indian J Endocrinol Metab. 2019; 23(3):278-281.

PMID: 31641627 PMC: 6683685. DOI: 10.4103/ijem.IJEM_635_18.